Literature DB >> 27220690

Wild type huntingtin toxicity in yeast: Implications for the role of amyloid cross-seeding in polyQ diseases.

A I Alexandrov1, G V Serpionov1, V V Kushnirov1, M D Ter-Avanesyan1.   

Abstract

Proteins with expanded polyglutamine (polyQ) regions are prone to form amyloids, which can cause diseases in humans and toxicity in yeast. Recently, we showed that in yeast non-toxic amyloids of Q-rich proteins can induce aggregation and toxicity of wild type huntingtin (Htt) with a short non-pathogenic polyglutamine tract. Similarly to mutant Htt with an elongated N-terminal polyQ sequence, toxicity of its wild type counterpart was mediated by induced aggregation of the essential Sup35 protein, which contains a Q-rich region. Notably, polymerization of Sup35 was not caused by the initial benign amyloids and, therefore, aggregates of wild type Htt acted as intermediaries in seeding Sup35 polymerization. This exemplifies a protein polymerization cascade which can generate a network of interdependent polymers. Here we discuss cross-seeded protein polymerization as a possible mechanism underlying known interrelations between different polyQ diseases. We hypothesize that similar mechanisms may enable proteins, which possess expanded Q-rich tracts but are not associated with diseases, to promote the development of polyQ diseases.

Entities:  

Keywords:  Amyloid; Huntington disease; Sup35; polyQ; polyglutamine; polymerization cross-seeding; yeast

Mesh:

Substances:

Year:  2016        PMID: 27220690      PMCID: PMC4981198          DOI: 10.1080/19336896.2016.1176659

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  61 in total

1.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

Authors:  M DiFiglia; E Sapp; K O Chase; S W Davies; G P Bates; J P Vonsattel; N Aronin
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

2.  Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells.

Authors:  A Kazantsev; E Preisinger; A Dranovsky; D Goldgaber; D Housman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

3.  Non-expanded polyglutamine proteins in intranuclear inclusions of hereditary ataxias--triple-labeling immunofluorescence study.

Authors:  T Uchihara; H Fujigasaki; S Koyano; A Nakamura; S Yagishita; K Iwabuchi
Journal:  Acta Neuropathol       Date:  2001-08       Impact factor: 17.088

4.  Searching for modulating effects of SCA2, SCA6 and DRPLA CAG tracts on the Machado-Joseph disease (SCA3) phenotype.

Authors:  L Jardim; I Silveira; M L Pereira; M do Céu Moreira; P Mendonça; J Sequeiros; R Giugliani
Journal:  Acta Neurol Scand       Date:  2003-03       Impact factor: 3.209

5.  Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease.

Authors:  L Djoussé; B Knowlton; M Hayden; E W Almqvist; R Brinkman; C Ross; R Margolis; A Rosenblatt; A Durr; C Dode; P J Morrison; A Novelletto; M Frontali; R J A Trent; E McCusker; E Gómez-Tortosa; D Mayo; R Jones; A Zanko; M Nance; R Abramson; O Suchowersky; J Paulsen; M Harrison; Q Yang; L A Cupples; J F Gusella; M E MacDonald; R H Myers
Journal:  Am J Med Genet A       Date:  2003-06-15       Impact factor: 2.802

6.  Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes.

Authors:  Sophie Tezenas du Montcel; Alexandra Durr; Peter Bauer; Karla P Figueroa; Yaeko Ichikawa; Alessandro Brussino; Sylvie Forlani; Maria Rakowicz; Ludger Schöls; Caterina Mariotti; Bart P C van de Warrenburg; Laura Orsi; Paola Giunti; Alessandro Filla; Sandra Szymanski; Thomas Klockgether; José Berciano; Massimo Pandolfo; Sylvia Boesch; Bela Melegh; Dagmar Timmann; Paola Mandich; Agnès Camuzat; Jun Goto; Tetsuo Ashizawa; Cécile Cazeneuve; Shoji Tsuji; Stefan-M Pulst; Alfredo Brusco; Olaf Riess; Alexis Brice; Giovanni Stevanin
Journal:  Brain       Date:  2014-06-26       Impact factor: 13.501

7.  Evaluation of polyglutamine repeats in autosomal dominant Parkinson's disease.

Authors:  Chikara Yamashita; Hiroyuki Tomiyama; Manabu Funayama; Saeko Inamizu; Maya Ando; Yuanzhe Li; Hiroyo Yoshino; Takehisa Araki; Tadashi Ichikawa; Yoshiro Ehara; Kinya Ishikawa; Hidehiro Mizusawa; Nobutaka Hattori
Journal:  Neurobiol Aging       Date:  2014-01-25       Impact factor: 4.673

Review 8.  Model organisms reveal insight into human neurodegenerative disease: ataxin-2 intermediate-length polyglutamine expansions are a risk factor for ALS.

Authors:  Nancy M Bonini; Aaron D Gitler
Journal:  J Mol Neurosci       Date:  2011-06-10       Impact factor: 3.444

9.  Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation.

Authors:  M K Perez; H L Paulson; S J Pendse; S J Saionz; N M Bonini; R N Pittman
Journal:  J Cell Biol       Date:  1998-12-14       Impact factor: 10.539

10.  Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1.

Authors:  Anatoli B Meriin; Xiaoqian Zhang; Xiangwei He; Gary P Newnam; Yury O Chernoff; Michael Y Sherman
Journal:  J Cell Biol       Date:  2002-06-10       Impact factor: 10.539

View more
  3 in total

1.  Proteolysis: a double-edged sword for the development of amyloidoses.

Authors:  Atsushi Okamoto; Nao Hosoda; Shin-Ichi Hoshino
Journal:  Prion       Date:  2018-09-09       Impact factor: 3.931

Review 2.  Role of Nuclear Factor Kappa B (NF-κB) Signalling in Neurodegenerative Diseases: An Mechanistic Approach.

Authors:  Shareen Singh; Thakur Gurjeet Singh
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

3.  The Impact of ESCRT on Aβ1-42 Induced Membrane Lesions in a Yeast Model for Alzheimer's Disease.

Authors:  Gernot Fruhmann; Christelle Marchal; Hélène Vignaud; Mathias Verduyckt; Nicolas Talarek; Claudio De Virgilio; Joris Winderickx; Christophe Cullin
Journal:  Front Mol Neurosci       Date:  2018-11-05       Impact factor: 5.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.